Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
Researchers identify novel molecular pathway that suppresses the spread of glioblastoma

Researchers identify novel molecular pathway that suppresses the spread of glioblastoma

Powerful injectable gel provides hope for preventing glioblastoma relapse

Powerful injectable gel provides hope for preventing glioblastoma relapse

Genetic signatures may help predict immunotherapy response in patients with bladder cancer

Genetic signatures may help predict immunotherapy response in patients with bladder cancer

New glioma drug may represent a paradigm for designing therapeutics exploiting specific DNA repair

New glioma drug may represent a paradigm for designing therapeutics exploiting specific DNA repair

New discovery may open the door to targeted treatments for two types of rhabdomyosarcoma

New discovery may open the door to targeted treatments for two types of rhabdomyosarcoma

Repurposing an antipsychotic drug to treat various types of cancer

Repurposing an antipsychotic drug to treat various types of cancer

New biomimetic formulation developed to tackle glioblastoma multiforme

New biomimetic formulation developed to tackle glioblastoma multiforme

New study to investigate focused ultrasound's role in addressing neurofibromatosis type 2

New study to investigate focused ultrasound's role in addressing neurofibromatosis type 2

The Mark Foundation for Cancer Research announces latest ASPIRE awards for eight outstanding projects

The Mark Foundation for Cancer Research announces latest ASPIRE awards for eight outstanding projects

Brown researchers develop an advanced way to isolate single cells from complex tissues

Brown researchers develop an advanced way to isolate single cells from complex tissues

Activation of the STING pathway could help make glioblastoma multiforme more susceptible to immunotherapy

Activation of the STING pathway could help make glioblastoma multiforme more susceptible to immunotherapy

MIT chemists discover how changes in a shape-shifting receptor trigger cell growth

MIT chemists discover how changes in a shape-shifting receptor trigger cell growth

Researchers identify biomarkers that could be targets for novel drugs to treat glioblastoma

Researchers identify biomarkers that could be targets for novel drugs to treat glioblastoma

Conceptual framework to examine the patterns of copy number alterations in human cancer

Conceptual framework to examine the patterns of copy number alterations in human cancer

Researchers identify a signature of three genes linked to positive response to blood cancer therapy

Researchers identify a signature of three genes linked to positive response to blood cancer therapy

Combination of three technologies makes potential treatment effective against aggressive brain tumor

Combination of three technologies makes potential treatment effective against aggressive brain tumor

Treatment with immunity-boosting protein enhances the function of CAR-T cells in fighting blood cancers

Treatment with immunity-boosting protein enhances the function of CAR-T cells in fighting blood cancers

New molecule kills a broad spectrum of hard-to-treat cancers

New molecule kills a broad spectrum of hard-to-treat cancers

Proteomic analysis of 2002 tumors reveals 11 distinct pan-cancer molecular subtypes

Proteomic analysis of 2002 tumors reveals 11 distinct pan-cancer molecular subtypes

New compound shows promise to kill a range of hard-to-treat cancer types

New compound shows promise to kill a range of hard-to-treat cancer types